Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People whose heart and circulation are stable (not in a state of shock or collapse)
- People who have a type of irregular heartbeat called atrial fibrillation that is not caused by a problem with the heart valves
- People whose doctor has decided, based on a clinical assessment, that starting apixaban (a blood-thinning medication) is appropriate for them
- People who have never taken apixaban before
Who may not be able to join:
- People with a history of a severe type of swelling called angioneurotic edema (a condition causing sudden swelling under the skin)
- People who are currently experiencing significant active bleeding
- People who have a bleeding disorder, whether inherited or developed over time
- People who have a cancer diagnosis
- People who currently have or have recently had a stomach or intestinal ulcer
- People who have enlarged veins in the food pipe (esophageal varices), confirmed or suspected
- People with a history of abnormal connections between arteries and veins, aneurysms, or unusual blood vessel formations in or around the spine or brain
- People who have an artificial heart valve
- People with liver cirrhosis or active liver disease that affects the blood's ability to clot, with a significant risk of bleeding
- People whose kidneys are functioning at a very low level, including those on dialysis (confirm with trial site regarding specific kidney function thresholds)
- People who are currently taking any other blood-thinning (anticoagulant) medications
- People who are pregnant or breastfeeding
- People who have used apixaban at any point in the past
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +387 62 478 535
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite primary outcome including incidence of major bleeding and clinically relevant non-major bleeding
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.